Alpha-Lipoic Acid Gelatin Wound Dressing for ROS and MMP Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Chronic wounds such as venous ulcers and diabetic ulcers face challenges in healing due to prolonged inflammation and excess reactive oxygen species (ROS) and matrix metalloproteinases (MMPs), which damage surrounding tissue and prevent normal wound healing.
Innovation Solution
A biologically active composition comprising alpha-lipoic acid derivatives and gelatin, applied as a coating on a scaffold within a reduced-pressure wound dressing system, helps reduce ROS levels and regulate MMP activity, promoting wound healing by forming a sacrificial substrate for MMPs and providing mechanical integrity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional absorbent dressings or hydrocolloid gels are used to manage wound environment and moisture balance, then wound management is improved, but active promotion of wound healing is insufficient
Solution Approach 1:
The patent introduces alpha-lipoic acid and antioxidants as intermediary substances that mediate between the wound environment and the healing process. These compounds actively neutralize ROS and modulate MMP activity, transforming the passive wound management approach into an active healing promotion strategy while maintaining the protective wound environment.
Solution Approach 2:
The invention changes the chemical parameters of the wound environment by introducing antioxidants that alter ROS levels and MMP activity. This transforms the wound from a state of excessive oxidation and proteolysis to a more balanced state conducive to healing, addressing both management and active healing promotion.
2Object-affected harmful factors
If antimicrobial agents such as silver or iodine are added to wound dressings to create a barrier to microorganisms or reduce microbial load, then infection prevention is improved, but they do not actively promote wound healing
Solution Approach 1:
The patent employs alpha-lipoic acid and antioxidants that serve multiple functions: they act as antimicrobial agents to control microorganisms, while simultaneously neutralizing ROS and modulating MMP activity to actively promote wound healing. This multi-functionality resolves the contradiction between infection prevention and healing promotion.
Solution Approach 2:
The invention combines antioxidants with antimicrobial properties alongside traditional wound dressing materials, creating a composite dressing system that provides both microbial control and active healing promotion through the dual mechanisms of antimicrobial action and ROS/MMP modulation.
3Object-generated harmful factors
If the inflammatory phase lasts too long due to patient nutrition, co-morbidities, or poor blood circulation, then ROS are produced to kill bacteria, but excess ROS damage surrounding healthy tissue including collagen
Solution Approach 1:
The patent converts the harmful excess ROS into a beneficial controlled process by introducing antioxidants that selectively neutralize excess ROS while preserving the physiological ROS needed for bacterial killing. This transforms the harmful oxidative stress into a controlled antioxidant therapy that maintains immune function while protecting healthy tissue.
Solution Approach 2:
Antioxidants serve as intermediary substances that mediate between the immune system's ROS production for bacterial killing and the protection of healthy tissue. They selectively interact with excess ROS to neutralize them, allowing the immune system to maintain its bacterial killing capability while preventing damage to healthy collagen and cells.
4Stability of the object's composition
If excess ROS recruit matrix metallo proteases (MMPs) to the wound site, then tissue remodeling occurs, but in excess MMPs continually break down new tissue that is formed
Solution Approach 1:
The invention changes the concentration and activity parameters of MMPs by introducing antioxidants that modulate MMP expression and activity. This shifts the MMP balance from excessive breakdown activity to a controlled level that allows tissue remodeling while preserving new tissue formation, resolving the contradiction between remodeling and tissue strength.
5Reliability
If excess levels of ROS and MMPs create a sustained state of inflammation, then wound healing is prevented, but reducing inflammation may compromise the immune response
Solution Approach 1:
The patent converts the sustained inflammatory state from a harmful barrier to healing into a beneficial controlled process. By introducing antioxidants, the excessive inflammation is transformed into a moderated immune response that maintains pathogen defense while allowing healing progression, effectively converting the harmful chronic inflammation into a beneficial acute-like response.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of alpha-lipoic acid and gelatin in the wound dressing system effectively reduces ROS and MMP activity, facilitating normal wound healing by creating a conducive environment for tissue repair and preventing excessive tissue breakdown.
Implementation Method 1
Topical application of antioxidants to a wound may reduce ROS levels, subsequently helping a chronic wound to re-enter a normal healing state
Implementation Method 2
Some wound dressings on the market use various forms of natural collagen as a sacrificial substrate for MMPs because the collagen also provides the mechanical properties (integrity) necessary to form the dressing
Implementation Method 3
the collagen also provides the mechanical properties (integrity) necessary to form the dressing
Data Source
AI summary
According to an illustrative embodiment a method to promote healing of a wound is provided comprising contacting the wound with a biologically active composition comprising a lipoic acid derivative and gelatin. In another embodiment a wound dressing is provided comprising a scaffold coated with a biologically active composition comprising a lipoic acid derivative. In a further embodiment, a system is provided for treating a tissue site of a patient, the system comprising a reduced-pressure source to supply reduced pressure, a manifold to distribute reduced pressure to a tissue site and a scaffold coated with a biologically active composition comprising a lipoic acid derivative. Methods for producing such a system and scaffold are also disclosed.